biotech firesales Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	1/30/2007 9:15:24 PM
	Read Replies (1) of 3661

Inflazyme cut in half on the TSX today (was 0.25) and this one looks like it will make this thread tomorrow... 5:24PM YM BioSciences announces termination of tesmilifene Phase III trial in advanced breast cancer (YMI) 3.77 +0.04 : Co announces that the independent Data Safety Monitoring Board for the pivotal Phase III trial of tesmilifene in patients with metastatic or recurrent breast cancer has completed its third planned safety and efficacy analysis. The DSMB advised the co to stop the trial based on an interim analysis of 351 events, indicating it is very unlikely significant differences in overall survival will be shown between treatment arms as the data mature. The trial was not stopped due to safety concerns relating to the product. The co plans to submit data from this trial to an appropriate medical meeting after it completes its review

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next